Get a reply from this employer
Your resume and cover letter, tailored to exactly what they’re hiring for.
Predicta Biosciences in Somerville, MA is seeking a Senior Research Associate with deep expertise in cell isolation and flow cytometry to develop, optimize, and validate cell-based workflows powering clinical assays.
You will work with clinical, R&D, and computational biology teams to ensure robust, validated testing aligned with CLIA/CAP guidelines, including downstream NGS workflows and data documentation.
Predicta is building a molecular insights platform for blood cancer care. From a single blood sample, we generate longitudinal genomic and immune insights that help clinicians and researchers better understand disease biology, guide treatment decisions, and monitor disease evolution over time.
We are seeking highly skilled and motivated Senior Research Associate with expertise in cell isolation techniques and fluorescence-activated cell sorting (FACS) to join our team. This individual will play a key role in developing, optimizing, and validating cell-based workflows that power our clinical assays. The ideal candidate will bring strong technical expertise, thrive in a dynamic startup environment, and play a key role in delivering impactful diagnostic results that drive better patient outcomes.
This position is located in Somerville MA
This is a unique opportunity to be part of a mission-driven team advancing precision diagnostics for hematologic cancers. You'll play a key role in shaping the quality and performance of our clinical testing efforts and contribute directly to patient-impactful innovations.
The annual salary range for this position is $95,000-$115,000, with a 10% bonus opportunity. Base compensation is determined by factors such as experience, skills, education, qualifications, and geographic location. Actual compensation may vary, and new hires are typically not placed at or near the top of the range. Additional benefits include equity, flexible time off, a 401(k) plan, medical, dental, and vision coverage that 90% paid by Predicta, and a partially company-funded HSA.